AMTB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Amerant Bancorp Inc (AMTB) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has seen some positive revisions in analyst price targets and revenue growth, the significant drop in net income and EPS, coupled with hedge fund selling and lack of strong technical or proprietary trading signals, suggests it is better to hold off on investing right now.
The MACD histogram is negative and contracting, RSI is neutral at 46.469, and moving averages are converging, indicating no clear trend. Key support is at 21.54, and resistance is at 23.011. Overall, the technical indicators do not show a strong buying opportunity.
Analyst price targets have been raised recently, with Piper Sandler and Raymond James showing optimism about the company's future. Revenue grew by 14.56% YoY in Q4 2025.
Hedge funds have significantly increased selling activity, and there are no significant insider trades or recent news to drive positive sentiment. Technical indicators and proprietary trading signals do not support a buy.
In Q4 2025, revenue increased to $86.67 million (up 14.56% YoY), but net income dropped to $2.7 million (down 84% YoY), and EPS fell to $0.07 (down 82.5% YoY). The company is struggling with profitability despite revenue growth.
Analysts have recently raised price targets (e.g., Piper Sandler to $25, Raymond James to $23), but concerns about non-performing loans and non-GAAP charges remain. Ratings are mixed, with Market Perform and Overweight ratings.
